Bioage Labs Stock (NASDAQ: BIOA) stock price, news, charts, stock research, profile.
You can purchase shares of Bioage Labs (NASDAQ:BIOA) through any online brokerage.
Other companies in Bioage Labs’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Neumora Therapeutics (NASDAQ:NMRA), Aquestive Therapeutics (NASDAQ:AQST) and Telomir Pharmaceuticals (NASDAQ:TELO).
Bioage Labs has a consensus price target of $18.00.
The stock price for Bioage Labs (NASDAQ: BIOA) is $4.8915 last updated January 17, 2025 at 5:26 PM EST.
There are no upcoming dividends for Bioage Labs.
Bioage Labs’s Q4 earnings are confirmed for Saturday, February 15, 2025.
There is no upcoming split for Bioage Labs.
Bioage Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.